Diabetic Kidney Disease Global Market Report 2023
June 09, 2023 09:59 ET
|
ReportLinker
New York, June 09, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Diabetic Kidney Disease Global Market Report 2023" -...
Impel Pharmaceuticals Announces First Quarter 2023 Financial Results and Provides Business Update
May 12, 2023 08:00 ET
|
Impel Pharmaceuticals
Trudhesa® Achieved nTRx of Over 18.5K in Q1 2023; Increase of 112% vs. Q1 2022 Trudhesa Net Product Revenue in Q1 2023 Increased 149% vs. Q1 2022 to $4.4 Million Impel to Host Investor...
Chronic Kidney Disease Market is expected to hit USD 93.91 Bn by 2029 at a CAGR of 5.2 percent – says Maximize Market Research
May 12, 2023 04:27 ET
|
MAXIMIZE MARKET RESEARCH PRIVATE LIMITED
Pune, May 12, 2023 (GLOBE NEWSWIRE) -- A global Healthcare research and business-consulting firm, Maximize Market Research, has published a market intelligence report on the “Chronic Kidney Disease...
Impel Pharmaceuticals Announces Appointment of Michael W. Kalb as Chief Financial Officer
May 10, 2023 08:00 ET
|
Impel Pharmaceuticals
SEATTLE, May 10, 2023 (GLOBE NEWSWIRE) -- Impel Pharmaceuticals (NASDAQ: IMPL), a commercial-stage biopharmaceutical company with a mission to develop transformative therapies for people suffering...
Chronic Kidney Disease Pipeline Booms as 90+ Therapies Likely to Enter in the Treatment Domain | DelveInsight
May 08, 2023 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, May 08, 2023 (GLOBE NEWSWIRE) -- Chronic Kidney Disease Pipeline Booms as 90+ Therapies Likely to Enter in the Treatment Domain | DelveInsight Chronic kidney disease (CKD) is a...
5AM Ventures Celebrates 20th FDA Product Approval Investing in Breakthrough Science
March 23, 2023 10:19 ET
|
5AM Venture Management, LLC
SAN FRANCISCO and BOSTON, March 23, 2023 (GLOBE NEWSWIRE) -- 5AM Ventures is pleased that the U.S. Food and Drug Administration (FDA) approved REZZAYO™ (rezafungin for injection) for the treatment...
HOOKIPA Pharma Appoints Terry Coelho to its Board of Directors
March 13, 2023 07:00 ET
|
HOOKIPA Pharma Inc.
NEW YORK and VIENNA, March 13, 2023 (GLOBE NEWSWIRE) -- HOOKIPA Pharma Inc. (NASDAQ: HOOK, ‘HOOKIPA’), a company developing a new class of immunotherapeutics based on its proprietary arenavirus...
STOCKHOLDER ALERT: The M&A Class Action Firm Continues its Investigation of the Merger – ATCX, CINC, ALR, MLVF
February 22, 2023 17:18 ET
|
Monteverde & Associates PC
NEW YORK, Feb. 22, 2023 (GLOBE NEWSWIRE) -- Juan Monteverde, founder and managing partner of the class action firm Monteverde & Associates PC (the “M&A Class Action Firm”), a national...
CinCor Pharma Announces Receipt of Minutes from End-of-Phase 2 Meeting with the U.S. Food and Drug Administration on Planned Phase 3 Program of Baxdrostat
February 21, 2023 08:00 ET
|
CinCor Pharma Inc
WALTHAM, Mass., Feb. 21, 2023 (GLOBE NEWSWIRE) -- CinCor Pharma, Inc. (“CinCor” or the “Company”) announced today completion of an End-of-Phase 2 meeting with the U.S. Food and Drug Administration...
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TIG, SESN, CINC, AJRD
February 16, 2023 08:54 ET
|
Halper Sadeh LLC
NEW YORK, Feb. 16, 2023 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or...